These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3513510)

  • 1. Antihypertensive and arterial anticalcinotic effects of calcium antagonists.
    Fleckenstein A; Frey M; Fleckenstein-Grün G
    Am J Cardiol; 1986 Feb; 57(7):1D-10D. PubMed ID: 3513510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of action of calcium antagonists in heart and vascular smooth muscle.
    Fleckenstein A; Fleckenstein-Grün G
    Eur Heart J; 1988 Jun; 9 Suppl H():95-9. PubMed ID: 3049099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental basis of the long-term therapy of arterial hypertension with calcium antagonists.
    Fleckenstein A; Frey M; Zorn J; Fleckenstein-Grün G
    Am J Cardiol; 1985 Dec; 56(16):3H-14H. PubMed ID: 2416214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amlodipine, a new 1,4-dihydropyridine calcium antagonist with a particularly strong antihypertensive profile.
    Fleckenstein A; Frey M; Zorn J; Fleckenstein-Grün G
    Am J Cardiol; 1989 Nov; 64(17):21I-34I. PubMed ID: 2530884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental vasoprotection by calcium antagonists against calcium-mediated arteriosclerotic alterations.
    Fleckenstein-Grün G; Thimm F; Czirfuzs A; Matyas S; Frey M
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S75-84. PubMed ID: 7898099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microcirculatory actions and uses of naturally-occurring (magnesium) and novel synthetic calcium channel blockers.
    Altura BM; Altura BT
    Microcirc Endothelium Lymphatics; 1984 Apr; 1(2):185-220. PubMed ID: 6400430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular effects of calcium channel antagonists: new evidence.
    Richard S
    Drugs; 2005; 65 Suppl 2():1-10. PubMed ID: 16398057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and chronic captopril, but not prazosin or nifedipine, normalize alterations in adrenergic intracellular Ca2+ handling observed in the mesenteric arterial tree of spontaneously hypertensive rats.
    Miquel R; Gisbert R; Serna E; Perez-Vizcaino F; Anselmi E; Noguera MA; Ivorra MD; D'Ocon MP
    J Pharmacol Exp Ther; 2005 Apr; 313(1):359-67. PubMed ID: 15615866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium antagonism in heart and vascular smooth muscle.
    Fleckenstein A
    Med Res Rev; 1985; 5(4):395-425. PubMed ID: 3906318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium overload--an important cellular mechanism in hypertension and arteriosclerosis.
    Fleckenstein-Grün G; Frey M; Thimm F; Hofgärtner W; Fleckenstein A
    Drugs; 1992; 44 Suppl 1():23-30. PubMed ID: 1283581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcium antagonists: effect on peripheral and coronary hemodynamics].
    Simon R
    Z Kardiol; 1984; 73 Suppl 2():79-88. PubMed ID: 6528705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium antagonists and atherosclerosis protection in hypertension.
    Hernández RH; Armas-Hernández MJ; Velasco M; Israili ZH; Armas-Padilla MC
    Am J Ther; 2003; 10(6):409-14. PubMed ID: 14624278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microvascular actions of calcium channel antagonists.
    Messing M; Van Essen H; Smith TL; Smits JF; Struyker-Boudier HA
    Eur J Pharmacol; 1991 Jun; 198(2-3):189-95. PubMed ID: 1650702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selectivity scale of calcium antagonists in the human cardiovascular system based on in vitro studies.
    Godfraind T; Salomone S; Dessy C; Verhelst B; Dion R; Schoevaerts JC
    J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S34-41. PubMed ID: 1282611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrophobic properties of novel dihydronaphthyridine calcium antagonists and biological activity in porcine isolated cardiac and vascular smooth muscle.
    Werner G; Klaus W; Kojda G; Fricke U
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):337-44. PubMed ID: 1961259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium antagonists. Clinical use in the treatment of systemic hypertension.
    Spivack C; Ocken S; Frishman WH
    Drugs; 1983 Feb; 25(2):154-77. PubMed ID: 6339198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of nisoldipine on large coronary arteries in situ: inhibition of vasoconstriction induced by vasopressin.
    Saito T; Saeed M; Bing RJ
    Pharmacology; 1988; 37(2):85-93. PubMed ID: 3212040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of calcium antagonists.
    Schwartz A; Matlib MA; Balwierczak J; Lathrop DA
    Am J Cardiol; 1985 Mar; 55(7):3C-7C. PubMed ID: 3872055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive effects of intravenous administration of benidipine hydrochloride and some other calcium antagonists in conscious, spontaneously hypertensive rats.
    Karasawa A; Kubo K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1691-4. PubMed ID: 3219141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. History of calcium antagonists.
    Fleckenstein A
    Circ Res; 1983 Feb; 52(2 Pt 2):I3-16. PubMed ID: 6339106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.